Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Dig Dis Sci. 2020 Dec;65(12):3456–3462. doi: 10.1007/s10620-020-06550-6

Table 1.

Comparison of major society guidelines for hepatocellular carcinoma surveillance

Society American Association for the Study of Liver Diseases European Association for the Study of the Liver Japan Society of Hepatology Asian Pacific Association for the Study of the Liver
Population Child-Pugh A or B cirrhosis

Child-Pugh C cirrhosis awaiting transplant

Hepatitis B:
Asian males > 40 years
Asian females > 50 years
Family history of HCC
African and/or North American blacks
Child-Pugh A or B cirrhosis

Child-Pugh C cirrhosis awaiting transplant

Hepatitis B at intermediate or high risk of HCC according to PAGE-B score

Non-cirrhotic F3 patients, regardless of etiology, may be considered based on individual risk assessment
High risk:
Cirrhosis
Chronic hepatitis B
Chronic Hepatitis C

Extremely high risk:
Cirrhosis due to hepatitis B
Cirrhosis due to hepatitis C
Cirrhosis

Hepatitis B:
Asian males > 40 years
Asian females > 50 years
Family history of HCC

Africans > 20 years old
Modality Ultrasound +/− AFP Ultrasound Ultrasound + AFP, DCP, AFP-L3 Ultrasound + AFP
Surveillance interval Every 6 months Every 6 months Every 6 months for high risk patients
Every 3–4 months for extremely high risk patients
Every 6 months